Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Bernard

Showing results (211-220 of 244) with videos related to

Pageof 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2019
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY TrialLaurent Hocqueloux, François Raffi, Thierry Prazuck, et al.
Molecular Therapy. Nucleic Acids|August 6, 2024
Enhancing natural killer cells proliferation and cytotoxicity using imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNAChristophe Delehedde, Ivan Ciganek, Pierre Louis Bernard, et al.
Medicine|May 25, 2017
Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control studyAdrien Lemaignen, Idir Ghout, Aurélien Dinh, et al.
Frontiers in Microbiology|January 13, 2018
A Potential New Human Pathogen Belonging to <i>Helicobacter</i> Genus, Identified in a Bloodstream InfectionNathalie L van der Mee-Marquet, Lucie Bénéjat, Seydina M Diene, et al.
European Annals of Allergy and Clinical Immunology|June 23, 2004
[The Housing and Health Council]Carmel Charpin-Kadouch, Sandrine Boutin-Forzano, Marion Gouitaa, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort studyPaul Le Turnier, Dominique Navas, Denis Garot, et al.
Journal for Immunotherapy of Cancer|May 19, 2022
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunityPierre-Louis Bernard, Rebecca Delconte, Sonia Pastor, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on NomogramMatthieu Grégoire, Eric Dailly, Paul Le Turnier, et al.
BMJ Open|July 8, 2022
Does awake prone positioning prevent the use of mechanical respiratory support or death in COVID-19 patients on standard oxygen therapy hospitalised in general wards? A multicentre randomised controlled trial: the PROVID-19 protocolMai-Anh Nay, Benjamin Planquette, Christophe Perrin, et al.
The Journal of Antimicrobial Chemotherapy|March 16, 2021
Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trialThierry Prazuck, Renaud Verdon, Gwenaël Le Moal, et al.
Pageof 25

Showing results (211-220 of 244) with videos related to

Sort By:
Pageof 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2019
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY TrialLaurent Hocqueloux, François Raffi, Thierry Prazuck, et al.
Molecular Therapy. Nucleic Acids|August 6, 2024
Enhancing natural killer cells proliferation and cytotoxicity using imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNAChristophe Delehedde, Ivan Ciganek, Pierre Louis Bernard, et al.
Medicine|May 25, 2017
Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control studyAdrien Lemaignen, Idir Ghout, Aurélien Dinh, et al.
Frontiers in Microbiology|January 13, 2018
A Potential New Human Pathogen Belonging to <i>Helicobacter</i> Genus, Identified in a Bloodstream InfectionNathalie L van der Mee-Marquet, Lucie Bénéjat, Seydina M Diene, et al.
European Annals of Allergy and Clinical Immunology|June 23, 2004
[The Housing and Health Council]Carmel Charpin-Kadouch, Sandrine Boutin-Forzano, Marion Gouitaa, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort studyPaul Le Turnier, Dominique Navas, Denis Garot, et al.
Journal for Immunotherapy of Cancer|May 19, 2022
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunityPierre-Louis Bernard, Rebecca Delconte, Sonia Pastor, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on NomogramMatthieu Grégoire, Eric Dailly, Paul Le Turnier, et al.
BMJ Open|July 8, 2022
Does awake prone positioning prevent the use of mechanical respiratory support or death in COVID-19 patients on standard oxygen therapy hospitalised in general wards? A multicentre randomised controlled trial: the PROVID-19 protocolMai-Anh Nay, Benjamin Planquette, Christophe Perrin, et al.
The Journal of Antimicrobial Chemotherapy|March 16, 2021
Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trialThierry Prazuck, Renaud Verdon, Gwenaël Le Moal, et al.
Pageof 25